No Level 4 CDC Travel Health Notice has been issued in 2026, with current surveillance showing no outbreaks meeting the agency’s strict criteria of extreme health risk where no precautions suffice. Official CDC and WHO data indicate ongoing monitoring of pathogens including Ebola Bundibugyo (Level 3 in the Democratic Republic of the Congo), influenza, and mpox, yet transmission remains moderate without novel high-fatality strains or exponential growth. Model projections and situational reports through late May reflect stable patterns unlikely to trigger “Avoid All Travel” status absent a major escalation. Trader consensus at 76% for “No” reflects the rarity of such designations and the absence of imminent catalysts before year-end, though new variant emergence or surveillance updates could shift conditions.